Ajooni Biotech balance sheet

·UnclassifiedChart ›

As of Mar 2026

Total assets: ₹120cr+26.6% on Mar 2025
Shareholders' equity: ₹91.2cr+3.5% on Mar 2025
Total debt: ₹17.8cr+815.7% on Mar 2025
Cash and investments: ₹0.4cr−93.9% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	25.9	10.9	10.3	—
	0.0	0.3	0.9	0.3
	0.4	0.5	0.0	—
	2.4	3.5	2.1	3.7
	15.0	15.1	0.0	—
	17.4	18.6	2.1	—
	0.5	0.4	0.3	0.3
	1.7	2.4	1.5	1.5
	45.9	33.0	15.2	—
	39.5	24.0	15.4	7.0
	17.8	16.2	13.0	20.6
	0.4	6.8	0.4	—
	14.1	13.3	3.5	4.0
	0.7	0.3	0.0	0.2
	33.1	36.6	16.9	—
	1.9	1.4	0.1	—
	74.5	62.0	32.3	—
	120	95.1	47.5	58.7
Equity
	34.4	34.4	17.5	17.5
	56.7	53.6	25.2	24.1
	91.2	88.1	42.7	—
	91.2	88.1	42.7	—
Liabilities
	1.5	1.9	1.7	1.7
	0.3	0.2	0.0	0.1
	1.8	2.2	1.7	—
	0.0	0.0	0.1	—
	1.8	2.2	1.8	—
	16.2	0.0	0.5	—
	8.9	3.5	1.6	10.1
	0.0	0.0	0.0	—
	25.2	3.5	2.1	—
	0.0	0.0	0.0	—
	1.5	1.0	0.9	0.5
	0.7	0.3	0.1	1.1
	27.3	4.8	3.0	—
	29.2	7.0	4.8	—
	120	95.1	47.5	58.7
Trade payables — MSME split
	4.9	3.5	—	—
	4.0	0.0	—	—
Regulatory disclosures — filed alongside, not part of the B/S
	0.2	0.0	—	—
	0.2	0.0	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

AJOONI₹2.90

Ajooni Biotech Limited

· Unclassified

₹ CrorePeersTOUCHWOOD RKEC RAJMET BANKA AAKASH GANGAFORGE GLOBE AGROPHOSMcap ₹50 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	—	10.3	10.9	25.9	25.9
+ Capital Work-in-Progress	0.3	0.9	0.3	0.0	0.0
+ Other Intangibles	—	0.0	0.5	0.4	0.4
+ Non-current Investments	3.7	2.1	3.5	2.4	2.4
+ Other Non-current Financial Assets	—	0.0	15.1	15.0	15.0
Non-current Financial Assets	—	2.1	18.6	17.4	17.4
+ Deferred Tax Assets	0.3	0.3	0.4	0.5	0.5
+ Other Non-current Assets	1.5	1.5	2.4	1.7	1.7
Total Non-current Assets	—	15.2	33.0	45.9	45.9
Current Assets
+ Inventories	7.0	15.4	24.0	39.5	39.5
+ Trade Receivables	20.6	13.0	16.2	17.8	17.8
+ Cash & Cash Equivalents	—	0.4	6.8	0.4	0.4
+ Short-term Loans	4.0	3.5	13.3	14.1	14.1
+ Other Current Financial Assets	0.2	0.0	0.3	0.7	0.7
Current Financial Assets	—	16.9	36.6	33.1	33.1
+ Other Current Assets	—	0.1	1.4	1.9	1.9
Total Current Assets	—	32.3	62.0	74.5	74.5
Total Assets	58.7	47.5	95.1	120.4	120.4
Equity
+ Equity Share Capital	17.5	17.5	34.4	34.4	34.4
+ Other Equity / Reserves	24.1	25.2	53.6	56.7	56.7
Equity — Owners of Parent	—	42.7	88.1	91.2	91.2
Total Equity	—	42.7	88.1	91.2	91.2
Liabilities
+ Borrowings — Non-current	1.7	1.7	1.9	1.5	1.5
+ Other Non-current Financial Liab	0.1	0.0	0.2	0.3	0.3
Non-current Financial Liabilities	—	1.7	2.2	1.8	1.8
+ Provisions — Non-current	—	0.1	0.0	0.0	0.0
Non-current Liabilities	—	1.8	2.2	1.8	1.8
+ Borrowings — Current	—	0.5	0.0	16.2	16.2
+ Trade Payables	10.1	1.6	3.5	8.9	8.9
+ Other Current Financial Liab	—	0.0	0.0	0.0	0.0
Current Financial Liabilities	—	2.1	3.5	25.2	25.2
+ Provisions — Current	—	0.0	0.0	0.0	0.0
+ Current Tax Liabilities	0.5	0.9	1.0	1.5	1.5
+ Other Current Liabilities	1.1	0.1	0.3	0.7	0.7
Current Liabilities	—	3.0	4.8	27.3	27.3
Total Liabilities	—	4.8	7.0	29.2	29.2
Total Equity & Liabilities	58.7	47.5	95.1	120.4	120.4
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	3.5	4.9	4.9
+ Dues to Other Creditors — Current	—	—	0.0	4.0	4.0
Regulatory Disclosures — filed alongside, not part of the B/S
Outstanding Loans / Revolving Facilities	—	—	0.0	0.2	0.2
Total Financial Indebtedness	—	—	0.0	0.2	0.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.